Description
Book SynopsisAdvocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials and monitoring systems in the US and Germany.
Trade ReviewThis clear and persuasive book is the first to provide a detailed cross-national comparison of the politics of pharmaceutical drug regulation. Anyone concerned with understanding how governments, social movements, professional groups, and corporations determine which drugs end up on our pharmacy shelves should read this book carefully.(Steven Epstein, University of California, San Diego, author of
Impure Science: AIDS, Activism, and the Politics of Knowledge)|Daemmrich uses a comparative study of pharmaceutical regulation in the U.S. and Germany to show that in order for medical globalization to be successful, it must accommodate persisting social and political variation even when technical standardization has been achieved. He looks at the relationships among governments, doctors, the pharmaceutical industry, and patients in case studies of an antibiotic, a sedative, a heart medication, a cancer therapy, and an AIDS drug.
